SCHEMBL30993291

SCHEMBL30993291

COC(=O)c1ccc(-c2cc3cccc(Br)c3cn2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.45
DYRK1A Q13627 1/20 0.45
MAPK1 P28482 1/20 0.43
HPGD P15428 2/20 0.41
IDO1 P14902 9/20 0.40
TDO2 P48775 9/20 0.40
MAPT P10636 3/20 0.40
CYP1A2 P05177 2/20 0.40
GAA P10253 1/20 0.40
RECQL P46063 1/20 0.40
KDM4E B2RXH2 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
PDE5A O76074 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
PKM P14618 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17977204 0.86 LCK (0.59) LCKMAPK1HPGDMAPTCYP1A2
SCHEMBL31601499 0.85 LCK (0.45) LCKDYRK1AMAPK1HPGDIDO1
SCHEMBL31248735 0.82 TDO2 (0.40) LCKIDO1TDO2
SCHEMBL31248750 0.81 TDO2 (0.43) IDO1TDO2
SCHEMBL30992932 0.78 DYRK1A (0.41) LCKDYRK1AMAPK1HPGDIDO1
SCHEMBL31023144 0.78 DYRK1A (0.41) LCKDYRK1AMAPK1HPGDIDO1
SCHEMBL1872723 0.78 GABRA1 (0.50) LCKMAPK1HPGDMAPTCYP1A2
SCHEMBL13680554 0.76 GRM5 (0.53) LCKDYRK1AMAPK1HPGDKDM4E
SCHEMBL31491983 0.74 POLB (0.40) LCKDYRK1AMAPK1HPGDMAPT
SCHEMBL23380565 0.74 MAPT (0.51) DYRK1AMAPK1MAPTCYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720057-A2 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2026-04-08 EP disclosed
WO-2025049976-A1 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF ONCOPIA THERAPEUTICS, INC. D/B/A SK LIFE SCIENCE LABS (US) 2025-03-06 WO disclosed
WO-2025049994-A1 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF ONCOPIA THERAPEUTICS, INC. D/B/A SK LIFE SCIENCE LABS (US) 2025-03-06 WO disclosed
WO-2024249888-A2 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF ONCOPIA THERAPEUTICS, INC. D/B/A SK LIFE SCIENCE LABS (US) 2024-12-05 WO disclosed
WO-2024130095-A9 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-08-02 WO disclosed
WO-2024130095-A1 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-06-20 WO disclosed